U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Laurence Rickles TEVA PHARMACEUTICALS USA, INC. |
---|---|
Address | 400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States |
Date | Description | Action Tags | Code |
---|---|---|---|
Apr-05-2022 | NEW APPLICATION ENTERED | NWAPI | |
Apr-06-2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Sep-20-2022 | ASSIGNED TO EXAMINER | DOCKD | |
Sep-25-2022 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
Oct-12-2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Nov-01-2022 | PUBLISHED FOR OPPOSITION | PUBOA | |
Nov-01-2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Dec-27-2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
Jul-31-2023 | ABANDONMENT - NO USE STATEMENT FILED | ABN6S | |
Jul-31-2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | MAB6E | |
Aug-01-2023 | TEAS PETITION TO REVIVE RECEIVED | PROAI | |
Aug-01-2023 | PETITION TO REVIVE-GRANTED | PETGO | |
Aug-01-2023 | SOU EXTENSION RECEIVED WITH TEAS PETITION | TPEXI | |
Aug-02-2023 | NOTICE OF REVIVAL - E-MAILED | NREVE | |
Aug-29-2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | AITUA | |
Jun-27-2023 | SOU EXTENSION 1 FILED | EXT1S | |
Aug-29-2023 | SOU EXTENSION 1 GRANTED | EX1GS | |
Aug-30-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Dec-20-2023 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Dec-20-2023 | SOU EXTENSION 2 FILED | EXT2S | |
Dec-20-2023 | SOU EXTENSION 2 GRANTED | EX2GS | |
Dec-22-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Jun-13-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Jun-13-2024 | SOU EXTENSION 3 FILED | EXT3S | |
Jun-13-2024 | SOU EXTENSION 3 GRANTED | EX3GS | |
Jun-13-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE |